Volume Alert - NEM 19.71 Newmont Mining Corp $NEM Hit a

New Post Public Reply Private Reply Replies (0) Message Board

Nov 19, 2014 at 1:00 PM

Volume Alert - NEM 19.71 Newmont Mining Corp $NEM Hit a high today of 19.97 Closing the day 10:30 at 19.71 -0.19 -0.95% With a day low of 19.59 and a total volume of 1,802,817.

NEM Recent Posts: http://investorshangout.com/Newmont-Mining-Corp-NEM-51987/

NEM Newmont Mining Corp Recent Headline News

Early Glance: Gold companies
AP - 58 mins ago
NEW YORK (AP) — Shares of some top gold companies are mixed at 10 a.m.:
ABX.TO: 14.61 (-0.43), ABX: 12.88 (-0.41), NEM: 19.62 (-0.28), GFI: 4.29 (-0.06)

The Future Of Gold - Quantified Mathematical Probabilities
Craig Mauk - at Seeking Alpha - 2 hrs 17 mins ago

ABX: 12.88 (-0.41), SLW: 21.16 (-0.19), NEM: 19.62 (-0.28), GG: 20.89 (-0.40)

Final Glance: Gold companies
AP - Tue Nov 18, 5:03PM CST
NEW YORK (AP) — Shares of some top gold companies were up at the close of trading:
ABX.TO: 14.61 (-0.43), ABX: 12.88 (-0.41), NEM: 19.62 (-0.28)

Newmont Mining Rises 3.43% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Nov 18, 4:28PM CST
Newmont Mining (NYSE:NEM) traded in a range yesterday that spanned from a low of $19.34 to a high of $19.96. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high of $19.36 on volume of 10.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NEM: 19.62 (-0.28)

Newmont Mining Set to Possibly Pullback After Yesterday's Rally of 3.43%
Comtex SmarTrend(R) - Tue Nov 18, 4:27PM CST
Newmont Mining (NYSE:NEM) traded in a range yesterday that spanned from a low of $19.34 to a high of $19.96. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high of $19.36 on volume of 10.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NEM: 19.63 (-0.27)

Gold miners rack up sharp gains as dollar slips
Seeking Alpha - at Seeking Alpha - Tue Nov 18, 2:59PM CST

GFI: 4.30 (-0.05), SILJ: 9.07 (-0.31), RING: 8.11 (-0.11), GLDX: 11.29 (-0.18), GDXJ: 28.91 (-0.45), AEM: 26.38 (-0.50), KGC: 2.90 (-0.06), SGDM: 19.11 (-0.44), JNUG: 5.62 (-0.31), SLW: 21.16 (-0.19), DUST: 25.52 (+1.43), AGI: 7.75 (-0.37), GDX: 19.90 (-0.40), JDST: 15.29 (+0.63), PSAU: 17.02 (-0.32), ABX: 12.88 (-0.41), GOLD: 69.50 (-0.84), AU: 9.66 (-0.61), NEM: 19.63 (-0.27), IAG: 2.33 (-0.09), SIL: 9.91 (-0.27), NUGT: 15.79 (-1.07), SLVP: 9.49 (-0.13), NGD: 4.28 (-0.06), RGLD: 70.52 (-0.80), AUY: 4.12 (-0.12), GG: 20.89 (-0.40)

Newmont Hails Suriname's Move to Join Merian Project - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 2:50PM CST
Newmont Mining Corporation (NEM) announced that the government of Suriname has decided to exercise its option to participate in the Merian Gold Project.
MVG: 7.69 (-0.25), LSG: 0.92 (-0.03), NEM: 19.63 (-0.27), BAA: 0.17 (unch)

Midday Glance: Gold companies
AP - Tue Nov 18, 12:25PM CST
NEW YORK (AP) — Shares of some top gold companies are up at 1 p.m.:
ABX.TO: 14.61 (-0.43), ABX: 12.88 (-0.41), NEM: 19.63 (-0.27), GFI: 4.30 (-0.05)

Newmont Mining Has Returned 23.2% Since SmarTrend Recommendation (NEM)
Comtex SmarTrend(R) - Tue Nov 18, 9:39AM CST
SmarTrend identified a Downtrend for Newmont Mining (NYSE:NEM) on September 8th, 2014 at $25.46. In approximately 2 months, Newmont Mining has returned 23.17% as of today's recent price of $19.56.
NEM: 19.63 (-0.27)

Newmont Mining (NEM) Crosses Pivot Point Resistance at $19.51
Comtex SmarTrend(R) - Tue Nov 18, 9:02AM CST
Shares of Newmont Mining (NYSE:NEM) opened today above their pivot of $19.09 and have already reached the first level of resistance at $19.51. Investors may be interested in a cross of the next upside pivot targets of $19.79 and $20.49.
NEM: 19.63 (-0.27)

The Zacks Analyst Blog Highlights:Barrick Gold, Agnico Eagle Mines, Kinross Gold, Newmont Mining and Richmont Mines
PR Newswire - Tue Nov 18, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Barrick Gold Corp. (NYSE:ABX-Free Report), Agnico Eagle Mines Ltd. (NYSE:AEM-Free Report), Kinross Gold Corporation (NYSE:KGC-Free Report), Newmont Mining Corporation (NYSE:NEM-Free Report) and Richmont Mines Inc. (AMEX:RIC-Free Report).
KGC: 2.90 (-0.06), NEM: 19.63 (-0.27)

Newmont Welcomes Suriname's Decision to Participate in the Merian Gold Project
Business Wire - Mon Nov 17, 8:52PM CST
Newmont Mining Corporation (NYSE: NEM) ("Newmont" or "the Company"

welcomed the government of Suriname's decision to exercise its option to participate in a fully-funded, 25 percent equity ownership stake in the Merian Gold Project.
NEM: 19.63 (-0.27)

Light at the End of the Tunnel for Gold Miners? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 2:09PM CST
Following the surge in gold prices last Friday, share prices of some of the gold miners in our coverage have moved up in tandem.
AEM: 26.38 (-0.50), ABX: 12.89 (-0.40), KGC: 2.90 (-0.06), NEM: 19.63 (-0.27), RIC: 3.08 (-0.04), AUY: 4.12 (-0.12), GG: 20.89 (-0.40)

Renaissance Gold Reports First Quarter 2015 Results
Filing Services Canada XHTML - Mon Nov 17, 11:45AM CST

REN.TO: 0.32 (+0.02), CAA.VN: 1.750 (-0.070), NEM: 19.63 (-0.27), NMC.TO: (), LSL.TO: 0.03 (-0.02)

Newmont Mining Earnings Review: 18 Days after Announcement Shares Down 5.8% (NEM)
Comtex SmarTrend(R) - Mon Nov 17, 10:53AM CST
When Newmont Mining (NYSE:NEM) reported earnings two weeks ago on October 30th, 2014, analysts, on average, expected the company to report earnings of $0.16 on sales of $1.7 billion. The company actually reported EPS of $0.50 on sales of $1.7 billion, beating EPS estimates by $0.34 and beating revenue estimates by $51.3 million. Since the company's report, shares of Newmont Mining have fallen from $20.33 to $19.15, representing a loss of 5.8% in the past 18 days.
NEM: 19.63 (-0.27)

What It Really Costs To Mine Gold: The Newmont Gold Third Quarter Edition
Hebba Investments - at Seeking Alpha - Mon Nov 17, 9:17AM CST

ABX: 12.89 (-0.40), GLD: 114.71 (-0.34), NEM: 19.63 (-0.27), GG: 20.88 (-0.41)

Watch for Newmont Mining to Potentially Pullback After Gaining 4.99% Yesterday
Comtex SmarTrend(R) - Fri Nov 14, 4:00PM CST
Newmont Mining (NYSE:NEM) traded in a range yesterday that spanned from a low of $17.75 to a high of $19.20. Yesterday, the shares gained 5.0%, which took the trading range above the 3-day high of $19.04 on volume of 13.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NEM: 19.63 (-0.27)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...